Mechanisms involved in the anti-inflammatory action of inhaled tea tree oil in mice

Experimental Biology and Medicine

Volumn 232, Issue 3, 2007, Pages 420-426

  Golab, Mateusz ^a   Skwarlo Sonta, Krystyna ^a  

^a UNIVERSITY OF WARSAW   (Poland)

Author keywords

COX; HPA; Immunomodulation; Inflammation; Tea tree oil

Indexed keywords

ANTALARMIN; PROSTAGLANDIN SYNTHASE; REACTIVE OXYGEN METABOLITE; TEA TREE OIL; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASPHYXIA; CELL ISOLATION; COLORIMETRY; CONTROLLED STUDY; ENZYME ACTIVITY; FLUOROMETRY; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOMODULATION; LEUKOCYTE; MALE; MOUSE; NONHUMAN; PERITONEAL DISEASE;

ADMINISTRATION, INHALATION; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL COUNT; CYCLOOXYGENASE INHIBITORS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNOLOGIC FACTORS; LEUKOCYTES; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MODELS, BIOLOGICAL; PERITONEAL CAVITY; PITUITARY-ADRENAL SYSTEM; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRIMIDINES; PYRROLES; REACTIVE OXYGEN SPECIES; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; TEA TREE OIL; TETRADECANOYLPHORBOL ACETATE; THIOPHENES; ZYMOSAN;

ANIMALIA; MELALEUCA ALTERNIFOLIA; MUS;

EID: 33847400946     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Carson CF, Mee BJ, Riley TV. Mechanism of action of Melaleuca alternifolia (tea tree) oil on Staphylococcus aureus, determined by time-kill, lysis, leakage and salt tolerance assays and electron microscopy. Antimicrob Agents Chemother 46:1914-1920, 2002.
2. Schnitzler P, Schon K, Reichling J. Antiviral activity of Australian tea tree oil and eucalyptus oil against herpes simplex virus in cell culture. Pharmazie 56:343-347, 2001.
3. Hammer KA, Carson CF, Riley TV. In vitro activity of Melaleuca alternifolia (tea tree) oil against dermatophytes and other filamentous fungi. J Antimicrob Chemother 50:195-199, 2002.
4. Finlay-Jones J, Hart P, Riley TV, Carson C. Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil) suppresses inflammatory mediator production by activated human monocytes. Inflamm Res 49:619-626, 2000.
5. Finlay-Jones J, Hart P, Riley TV, Carson C. The water-soluble components of the essential oil of Melaleuca alternifolia suppress the production of superoxide by human monocytes, but not neutrophils, activated in vitro. Inflamm Res 50:213-219, 2001.
6. Brand C, Grimbaldeston MA, Gamble JR, Drew J, Finlay-Jones JJ, Hart PH. Tea tree oil reduces swelling associated with the efferent phase of a contact hypersensitivity response. Inflamm Res 51:236-244, 2002.
7. Brand C, Townley SL, Finlay-Jones JJ, Hart PH. Tea tree oil reduces histamine-induced edema in murine ears. Inflamm Res 51:283-289, 2002.
8. Pearce AL, Finlay-Jones JJ, Hart PH. Reduction of nickel-induced contact hypersensitivity reactions by topical tea tree oil in humans. Inflamm Res 54:22-30, 2005.
9. Skopinska-Rozewska E, Sokolnicka I, Kleniewska D, Zwolska Z, Sommer E, Rogala E, Filewska M, Podsiadlo B, Augustynowicz-Kopec I, Konopacka-Brud I, Brud W. Antimicrobial and immunotropic action of essential oils. In: Xenobiotics Influence on the Immune System. Olsztyn, Poland: IRS, pp127-136, 1997 [in Polish].
10. Feijo de Mello AA, Feijo de Mello M, Carpenter LL, Price LH. Update on stress and depression: the role of hypothalamic-pituitary-adrenal (HPA) axis. Rev Bras Psiquiatr 25:231-238, 2003.
11. Dan G, Lall SB. Neuroendocrine modulation of immune system. Indian J Pharmacol 30:129-140, 1998.
12. Wlk M, Wang CC, Venihaki M, Liu J, Zhao D, Anton PM, Mykoniatis A, Pan A, Zacks J, Karalis K, Pothoulakis C. Corticotropin-releasing hormone antagonists possess anti-inflammatory effects in the mouse ileum. Gastroenterology 123:505-515, 2002.
13. Golab M, Burdzenia O, Majewski P, Skwarlo-Sonta K. Tea tree oil inhalations modify immunity in mice. J Appl Biomed 3:101-108, 2005.
14. Minghetti L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol 69:901-910, 2004.
15. Hinz B, Brune K. Cyclooxygenase-2 - 10 years later. J Pharmacol Exp Ther 300:367-375, 2002.
16. Paramo JA, Rodriguez JA, Beloqui O, Orbe J. Monocyte cyclooxygenase-2 activity: a new therapeutic target for atherosclerosis? Curr Drug Targets Cardiovasc Haematol Disord 5:303-311, 2005.
17. Hildebrand J, Sheferd G. Mechanism of olfactory discrimination: converging evidence for common principles across phyla. Ann Rev Neurosci 29:595-631, 1997.
18. Chadzińska M, Maj M, Ścisłowska-Czarnecka A, Przewłocka B, Płytycz B. Expression of proenkephalin (PENK) in inflammatory leukocytes during experimental peritonitis in Swiss mice. Pol J Pharmacol 53:715-718, 2001.
19. Ajuebor MN, Flower RJ, Hannon R, Christie M, Bowers K, Verity A, Perretti M. Endogenous monocyte chemoattractant protein-1 recruits monocytes in the Zymosan peritonitis model. J Leukoc Biol 63:108-116, 1998.
20. Majewski P, Markowska M, Laskowska H, Waloch M, Skwarlo-Sonta K. Effect of morphine on thioglycollate-induced peritonitis in chickens. Neuroendocrinol Lett 23:161-167, 2002.
21. Kołaczkowska E, Seljelid R, Płytycz B. Critical role of mast cells in morphine-mediated impairment of Zymosan-induced peritonitis in mice. Inflamm Res 50:415-421, 2001.
22. Van Pelt LJ, van Zwieten R, Weening RS, Roos D, Verhoeven AJ, Bolscher BG. Limitation on the use of dihydrorhodamine 123 for flow cytometric analysis of the neutrophil respiratory burst. J Immunol Met 191:187-196, 1996.
23. Kargman S, Wong E, Greig GM, Falgueyret JP, Cromlish W, Ethier D, Yergey JA, Riendeau D, Evans JF, Kennedy B, Tagari P, Francis DA, O'Neill GP. Mechanism of selective inhibition of human prostaglandin G/H synthase-1 and -2 in intact cells. Biochem Pharmacol 52:1113-1125, 1996.
24. Kulmacz RJ, Lands WEM. Requirements for hydroperoxide by the cyclooxygenase and peroxide activities of prostaglandin H synthase. Prostaglandins 25:531-540, 1983.
25. Leu SJ, Singh VK. Stimulation of interleukin-6 production by corticotropin-releasing factor. Cell Immunol 143:220-227, 1992.
26. Webster EL, Barrientos RM, Contoreggi C, Isaac MG, Ligier S, Gabry KE, Chrousos GP, McCarthy EF, Rice KC, Gold PW, Sternberg EM. Corticotropin releasing hormone (CRH) antagonist attenuates adjuvant induced arthritis: role of CRH in peripheral inflammation. J Rheumatol 29:1252-1261, 2002.
27. Tsatsanis C, Androulidaki A, Alissafi T, Charalampopoulos I, Dermitzaki E, Roger T, Gravanis A, Margioris AN. Corticotropin-releasing factor and the urocortins induce the expression of TLR4 in macrophages via activation of the transcription factors PU.1 and AP-1. J Immunol 176:1869-1877, 2006.
28. Kovar KA, Kovar DD, Johnson I. 1,8 Cineole was detected in the blood of mice following inhalation. Planta Med 53:315-318, 1987.
29. Buchbauer G, Jirovets L, Jager W, Plank C, Dietrich H. Fragrance compounds and essential oils with sedative effects upon inhalation. J Pharmacol Sci 82:660-664, 1993.
30. Umezu T. Pharmacological effects of plant-derived essential oils on the central nervous system. Aroma Res 3:376-382, 2002.
31. Lis-Balchin M. Essential oils and "aromatherapy": their modern role in healing. J R Soc Health 117:324-329, 1997.
32. Lledo PM, Gheusi G, Vincent JD. Information processing in the mammalian olfactory system. Physiol Rev 85:281-317, 2005.
33. Moynihan JA, Karp JD, Cohen N, Ader R. Immune deviation following stress odor exposure: role of endogenous opioids. J Neuroimmunol 102:145-153, 2000.